Projects per year
Organisation profile
Organisation profile
The International Ph.D. Program in Cell Therapy and Regenerative Medicine (IPCTRM) begin to recruit students for Fall semester in 2007. The mission of this program is to promote translational medicine and clinical trials of cell/stem cell based therapy. Research at IPCTRM provide diverse research fields, including immune cell applications in cancer treatment; blood and mesenchymal stem cells for regenerative processes, wound healing, graft-versus-host disease, and amyotrophic lateral sclerosis; and drug screening platform with cancer stem cells and disease-specific induced pluripotent stem cells. IPCTRM brings experts and scientists together to facilitate outstanding research not only in basic study but also emphasis on clinical translational medicine, and industrial cell/stem cell product development.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Heng-Kien Au
- Department of Obstetrics and Gynecology - Assistant Professor
- International Ph.D. Program in Cell Therapy and Regenerative Medicine - Joint-Appointment Assistant Professor
- Taipei Medical University Hospital - Visiting Staff
- TMU Research Center of Cell Therapy and Regeneration Medicine - Member
Person: Researcher
-
Thierry Pierre Robert Burnouf
- Graduate Institute of Biomedical Materials and Tissue Engineering - Professor
- International Ph.D. Program in Biomedical Engineering - Joint-Appointment Professor
- International Ph.D. Program in Cell Therapy and Regenerative Medicine - Joint-Appointment Professor
- Ph.D. Program in Neuroscience of Cognition and Consciousness - Joint-Appointment Professor
- TMU Research Center of Cell Therapy and Regeneration Medicine - Member
- TMU Research Center of Biomedical Devices - Member
- TMU Research Center of Neuroscience - Member
Person: Researcher
-
Jungshan Chang
- International Master/Ph.D. Program in Medicine - Joint-Appointment Associate Professor
- International Ph.D. Program in Cell Therapy and Regenerative Medicine - Joint-Appointment Associate Professor
- Graduate Institute of Medical Sciences - Professor
Person: Researcher
-
Hmgcs2 Maintains Heart Function by Stabilizing Mitochondrial Inner Membrane Integrity through Interaction with Vlcad.
Cheng, Y.-Y. (PI)
10/1/24 → 9/30/25
Project: A - Government Institution › b - National Science and Technology Council
-
Spatial Transcriptomic Exploration of Regional Specificity in Tissue Regeneration: Insights from the Heterogeneity of Avian Feather Stem Cell Microenvironments
Chang, W.-L. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
The Role of Retrotransposon in Alzheimer Disease
Hu, C.-J. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
An injectable in situ-forming hydrogel with self-activating genipin-chitosan (GpCS) cross-linking and an O2/Ca2+ self-supplying capability for wound healing and rapid hemostasis
Lin, C., Lu, T. W., Hsu, F. Y., Huang, T. W., Ho, M. H., Lu, H. T. & Mi, F. L., Mar 1 2025, In: Carbohydrate Polymers. 351, 123051.Research output: Contribution to journal › Article › peer-review
-
Extreme temperature increases the risk of COPD morbimortality: A systematic review and meta-analysis
Tran, H. M., Tsai, F. J., Lee, K. Y., Wang, Y. H., Yang, F. M., Ho, S. C., Bui, H. T. M., Hoang, L. N. N., Bui, L. T. M., Ho, K. F., Chung, K. F., Chuang, K. J. & Chuang, H. C., Jan 1 2025, In: Science of the Total Environment. 958, 178087.Research output: Contribution to journal › Review article › peer-review
-
Potential role of solid lipid curcumin particle (SLCP) as estrogen replacement therapy in mitigating TDP-43-related neuropathy in the mouse model of ALS disease
Majumder, P., Hsu, T. I., Hu, C. J., Huang, J. K., Lee, Y. C., Hsieh, Y. C., Ahsan, A. & Huang, C. C., Jan 2025, In: Experimental Neurology. 383, 114999.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset
-
Additional file 2 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y.-W. (Creator), Huang, C.-C. (Contributor), Changou, C. A. (Creator), Lu, L.-S. (Creator), Goubran, H. (Creator) & Burnouf, T. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12017382.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017382/1
Dataset
-
MOESM1 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Cheng, C.-C. (Contributor), Chiang, Y.-W. (Creator), Lim, K.-H. (Contributor), Chang, Y.-F. (Creator), Chang, J. (Creator), Ho, A.-S. (Contributor) & Sie, Z.-L. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.9993554.v1, https://doi.org/10.6084%2Fm9.figshare.9993554.v1
Dataset